Skip to Content

How does Tremfya work to treat plaque psoriasis?

Answers (1)

Official Answer by 20 Sep 2017

Tremfya (guselkumab) from Janssen Biotech, Inc. is used for the treatment of adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

Tremfya is a biologic therapy that selectively blocks only interleukin 23 (IL-23), an inflammatory cytokine that plays a key role in plaque psoriasis. IL-23 is found in the skin of patients with psoriasis, and leads to inflammatory reactions seen in psoriasis.

In studies, patients using Tremfya experienced significant improvement in clearance of skin lesions and greater improvement in their symptoms of plaque psoriasis, which included itch, pain, stinging, burning and skin tightness when compared with placebo.

See also: free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

What type of drug is Motegrity?

Updated 12 days ago 1 answerFAQ by

What disease is Elzonris (tagraxofusp-erzs) used to treat?

Updated 9 days ago 1 answerFAQ by

How do you use the ProAir Digihaler?

Updated 9 days ago 1 answerFAQ by

How many biosimilars have been approved in the United States?

Updated 8 days ago 1 answerFAQ by